Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitors

被引：0
|
作者：
Yuna Suzuki
Wu Wenwen
Tomohiko Ohta
Shin-ichi Hayashi
机构：
[1] Tohoku University,Department of Molecular and Functional Dynamics, Graduate School of Medicine
[2] St. Marianna University Graduate School of Medicine,Department of Translational Oncology
来源：
Breast Cancer | 2022年 / 29卷
关键词：
Breast cancer; DNA repair; CDK4/6 inhibitor; PARP inhibitor; Drug resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：77 / 91
页数：14
相关论文
共 50 条
  • [31] Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk
    Su, Chen-Hsien
    Chang, Wen-Shin
    Hu, Pei-Shin
    Hsiao, Chieh-Lun
    Ji, Hong-Xue
    Liao, Cheng-Hsi
    Yueh, Te-Cheng
    Chuang, Chin-Liang
    Tsai, Chia-Wen
    Hsu, Chin-Mu
    Lane, Hsien-Yuan
    Bau, Da-Tian
    CANCER GENOMICS & PROTEOMICS, 2015, 12 (06) : 359 - 367
  • [32] Cyclin D1 silencing impairs DNA double strand break repair, sensitizes BRCA1 wildtype ovarian cancer cells to olaparib
    Zhong, Qian
    Hu, Zhongyi
    Li, Qiao
    Yi, Tao
    Li, Jinke
    Yang, Hanshuo
    GYNECOLOGIC ONCOLOGY, 2019, 152 (01) : 157 - 165
  • [33] DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR)
    Hui-Chen Wu
    Lissette Delgado-Cruzata
    Nicola Machella
    Qiao Wang
    Regina M. Santella
    Mary Beth Terry
    Cancer Causes & Control, 2013, 24 : 2157 - 2168
  • [34] DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR)
    Wu, Hui-Chen
    Delgado-Cruzata, Lissette
    Machella, Nicola
    Wang, Qiao
    Santella, Regina M.
    Terry, Mary Beth
    CANCER CAUSES & CONTROL, 2013, 24 (12) : 2157 - 2168
  • [35] Influence of cellular localization of survivin and DNA double-strand break repair on the resistance of glioblastoma cells against alkylating and topoisomerase I inhibiting anticancer drugs
    Reich, Thomas
    Diesler, Kathrin
    Aasland, Dorthe
    Kaina, Bernd
    Christmann, Markus
    Tomicic, Maja
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S77 - S77
  • [36] Exome Sequencing of Breast Cancer Familial Pedigree and Functional Cellular Characterization Identifies Novel DNA Double-strand Break Repair Deficient Mutation
    Costa, H. A.
    Schlacher, K.
    Ford, J. M.
    Laurent, L. C.
    Bustamante, C. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S2 - S2
  • [37] SUSCEPTIBILITY TO BREAST CANCER AND INTRON 3 INS/DEL GENETIC POLYMORPHISM OF DNA DOUBLE-STRAND BREAK REPAIR GENE XRCC4
    Saadat, Mostafa
    Saadat, Shekoofeh
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2015, 34 (04) : 409 - 413
  • [38] In vitro model for DNA double-strand break repair analysis in breast cancer reveals cell type-specific associations with age and prognosis
    Deniz, Miriam
    Kaufmann, Julia
    Stahl, Andreea
    Gundelach, Theresa
    Janni, Wolfgang
    Hoffmann, Isabell
    Keimling, Marlen
    Hampp, Stephanie
    Ihle, Michaela
    Wiesmueller, Lisa
    FASEB JOURNAL, 2016, 30 (11): : 3786 - 3799
  • [39] Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells
    Khozooei, Shayan
    Lettau, Konstanze
    Barletta, Francesca
    Jost, Tina
    Rebholz, Simone
    Veerappan, Soundaram
    Franz-Wachtel, Mirita
    Macek, Boris
    Iliakis, George
    Distel, Luitpold, V
    Zips, Daniel
    Toulany, Mahmoud
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [40] Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells
    Shayan Khozooei
    Konstanze Lettau
    Francesca Barletta
    Tina Jost
    Simone Rebholz
    Soundaram Veerappan
    Mirita Franz-Wachtel
    Boris Macek
    George Iliakis
    Luitpold V. Distel
    Daniel Zips
    Mahmoud Toulany
    Journal of Experimental & Clinical Cancer Research, 41
12345